19-17226294-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024578.3(OCEL1):c.47C>T(p.Ser16Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000093 in 1,612,314 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024578.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OCEL1 | NM_024578.3 | c.47C>T | p.Ser16Leu | missense_variant | 1/6 | ENST00000215061.9 | NP_078854.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OCEL1 | ENST00000215061.9 | c.47C>T | p.Ser16Leu | missense_variant | 1/6 | 1 | NM_024578.3 | ENSP00000215061.3 |
Frequencies
GnomAD3 genomes AF: 0.000486 AC: 74AN: 152114Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000147 AC: 36AN: 244560Hom.: 0 AF XY: 0.000143 AC XY: 19AN XY: 133266
GnomAD4 exome AF: 0.0000514 AC: 75AN: 1460082Hom.: 0 Cov.: 33 AF XY: 0.0000468 AC XY: 34AN XY: 726232
GnomAD4 genome AF: 0.000493 AC: 75AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.000551 AC XY: 41AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.47C>T (p.S16L) alteration is located in exon 1 (coding exon 1) of the OCEL1 gene. This alteration results from a C to T substitution at nucleotide position 47, causing the serine (S) at amino acid position 16 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at